'It's safe': Made-in-India Covaxin gets thumbs up from Lancet

India's homegrown Covid-19 vaccine, Covaxin, has been declared "safe and immunogenic with no serious side effects" by Lancet that has published its phase 2 results.

Lancet has said that efficacy cannot be determined by phase 2 trials but the vaccine made by Hyderabad-based Bharat Biotech is "safe/immunogenic".

Covaxin was authorized for use in January before full clinical trial data leading to some concerns about its safety.

Bharat Biotech had last week said that interim analysis of Phase 3 of its trial showed Covaxin is 81% effective in protecting against Covid-19.

Also Read: PM Modi gets first dose of Covid-19 vaccine. Tweets pic & appeal